Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.7M
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
33.6M
-
Shares change
-
+1.43M
-
Total reported value, excl. options
-
$207M
-
Value change
-
+$7.11M
-
Put/Call ratio
-
0.07
-
Number of buys
-
52
-
Number of sells
-
-43
-
Price
-
$6.09
Significant Holders of Altimmune, Inc. - Common Stock (ALT) as of Q1 2022
122 filings reported holding ALT - Altimmune, Inc. - Common Stock as of Q1 2022.
Altimmune, Inc. - Common Stock (ALT) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.6M shares
of 80.7M outstanding shares and own 41.67% of the company stock.
Largest 10 shareholders include Nuveen Asset Management, LLC (3.25M shares), BlackRock Inc. (2.94M shares), Avidity Partners Management LP (2.87M shares), TANG CAPITAL MANAGEMENT LLC (2.57M shares), VANGUARD GROUP INC (1.82M shares), MORGAN STANLEY (1.41M shares), ARDSLEY ADVISORY PARTNERS LP (1.35M shares), SPHERA FUNDS MANAGEMENT LTD. (1.31M shares), BARCLAYS PLC (1.16M shares), and CITADEL ADVISORS LLC (1.12M shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.